{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T17:58:35Z","timestamp":1721757515962},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,2,25]],"date-time":"2014-02-25T00:00:00Z","timestamp":1393286400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s12185-014-1535-9","type":"journal-article","created":{"date-parts":[[2014,2,24]],"date-time":"2014-02-24T05:45:19Z","timestamp":1393220719000},"page":"542-552","source":"Crossref","is-referenced-by-count":6,"title":["Dysregulation of microRNAs and their association in the pathogenesis of T-cell lymphoma\/leukemias"],"prefix":"10.1007","volume":"99","author":[{"given":"Sho","family":"Ikeda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Tagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,25]]},"reference":[{"key":"1535_CR1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281\u201397.","journal-title":"Cell"},{"key":"1535_CR2","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","volume":"75","author":"RC Lee","year":"1993","unstructured":"Lee RC, Feinbaum RL, Ambros V. The c.elegance heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75:843\u201354.","journal-title":"Cell"},{"issue":"6772","key":"1535_CR3","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/35002607","volume":"403","author":"BJ Reinhart","year":"2000","unstructured":"Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegance. Nature. 2000;403(6772):901\u20136.","journal-title":"Nature"},{"issue":"5543","key":"1535_CR4","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1126\/science.1065062","volume":"294","author":"NC Lau","year":"2001","unstructured":"Lau NC, Lim LP, Weinstein EG, Bartel DP. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegance. Science. 2001;294(5543):858\u201362.","journal-title":"Science"},{"issue":"5543","key":"1535_CR5","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1126\/science.1064921","volume":"294","author":"M Lagos-Quintana","year":"2001","unstructured":"Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science. 2001;294(5543):853\u20138.","journal-title":"Science"},{"issue":"7","key":"1535_CR6","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","volume":"103","author":"S Volinia","year":"2006","unstructured":"Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA. 2006;103(7):2257\u201361.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"1535_CR7","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","volume":"6","author":"GA Calin","year":"2006","unstructured":"Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6(11):857\u201366.","journal-title":"Nat Rev Cancer"},{"issue":"34","key":"1535_CR8","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1200\/JCO.2009.24.0317","volume":"27","author":"MV Iorio","year":"2009","unstructured":"Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol. 2009;27(34):5848\u201356.","journal-title":"J Clin Oncol"},{"key":"1535_CR9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.gde.2013.01.004","volume":"23","author":"G Leva Di","year":"2013","unstructured":"Di Leva G, Croce CM. miRNA profiling of cancer. Curr Opin Genet Dev. 2013;23:3\u201311.","journal-title":"Curr Opin Genet Dev"},{"issue":"1","key":"1535_CR10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/imr.12050","volume":"253","author":"E Tili","year":"2013","unstructured":"Tili E, Michaille JJ, Croce CM. MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer. Immunol Rev. 2013;253(1):167\u201384.","journal-title":"Immunol Rev"},{"issue":"3","key":"1535_CR11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.blre.2013.04.002","volume":"27","author":"CH Lawrie","year":"2013","unstructured":"Lawrie CH. MicroRNAs in hematological malignancies. Blood Rev. 2013;27(3):143\u201354.","journal-title":"Blood Rev"},{"issue":"9","key":"1535_CR12","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1182\/blood-2012-05-402784","volume":"120","author":"L Lisio Di","year":"2012","unstructured":"Di Lisio L, Martinez N, Montes-Moreno S, Piris-Villaespesa M, Sanchez-Beato M, Piris MA. The role of miRNAs in the pathogenesis and diagnosis of B-cell lymphomas. Blood. 2012;120(9):1782\u201390.","journal-title":"Blood"},{"issue":"2","key":"1535_CR13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12185-010-0633-6","volume":"92","author":"A Kotani","year":"2010","unstructured":"Kotani A, Harnprasopwat R, Toyoshima T, Kawamata T, Tojo A. miRNAs in normal and malignant B cells. Int J Hematol. 2010;92(2):255\u201361.","journal-title":"Int J Hematol"},{"issue":"7","key":"1535_CR14","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/cas.12160","volume":"104","author":"H Tagawa","year":"2013","unstructured":"Tagawa H, Ikeda S, Sawada K. Role of microRNA in the pathogenesis of malignant lymphoma. Cancer Sci. 2013;104(7):801\u20139.","journal-title":"Cancer Sci"},{"key":"1535_CR15","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s12185-012-1198-3","volume":"96","author":"M Roschewski","year":"2012","unstructured":"Roschewski M, Dunleavy K, Wilson WH. Diffuse large B cell lymphoma: molecular targeted therapy. Int J Hematol. 2012;96:552\u201361.","journal-title":"Int J Hematol"},{"key":"1535_CR16","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s12185-012-1202-y","volume":"96","author":"G Salles","year":"2012","unstructured":"Salles G, Ghesqui\u00e8res H. Current and future management of follicular lymphoma. Int J Hematol. 2012;96:544\u201351.","journal-title":"Int J Hematol"},{"issue":"5654","key":"1535_CR17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1126\/science.1091903","volume":"303","author":"CZ Chen","year":"2004","unstructured":"Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science. 2004;303(5654):83\u20136.","journal-title":"Science"},{"issue":"8","key":"1535_CR18","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1186\/gb-2005-6-8-r71","volume":"6","author":"S Monticelli","year":"2005","unstructured":"Monticelli S, Ansel KM, Xiao C, Socci ND, Krichevsky AM, Thai TH, et al. MicroRNA profiling of the murine hematopoietic system. Genome Biol. 2005;6(8):R71.","journal-title":"Genome Biol"},{"issue":"17","key":"1535_CR19","doi-asserted-by":"crossref","first-page":"7080","DOI":"10.1073\/pnas.0702409104","volume":"104","author":"B Zhou","year":"2007","unstructured":"Zhou B, Wang S, Mayr C, Bartel DP, Lodish HF. miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc Natl Acad Sci USA. 2007;104(17):7080\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1535_CR20","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cell.2007.07.021","volume":"131","author":"C Xiao","year":"2007","unstructured":"Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, Wang J, et al. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell. 2007;131(1):146\u201359.","journal-title":"Cell"},{"issue":"7","key":"1535_CR21","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/ni1085","volume":"5","author":"TP Bender","year":"2004","unstructured":"Bender TP, Kremer CS, Kraus M, Buch T, Rajewsky K. Critical functions for c-Myb at three checkpoints during thymocyte development. Nat Immunol. 2004;5(7):721\u20139.","journal-title":"Nat Immunol"},{"issue":"41","key":"1535_CR22","doi-asserted-by":"crossref","first-page":"14853","DOI":"10.1073\/pnas.0405338101","volume":"101","author":"YK Lieu","year":"2004","unstructured":"Lieu YK, Kumar A, Pajerowski AG, Rogers TJ, Reddy EP. Requirement of c-myb in T cell development and in mature T cell function. Proc Natl Acad Sci USA. 2004;101(41):14853\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"26","key":"1535_CR23","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.1182\/blood-2010-12-326629","volume":"117","author":"M Ghisi","year":"2011","unstructured":"Ghisi M, Corradin A, Basso K, Frasson C, Serafin V, Mukherjee S, et al. Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150. Blood. 2011;117(26):7053\u201362.","journal-title":"Blood"},{"issue":"5","key":"1535_CR24","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/sj.emboj.7600996","volume":"25","author":"A Vacca","year":"2006","unstructured":"Vacca A, Felli MP, Palermo R, Di Mario G, Calce A, Di Giovine M, et al. Notch3 and pre-TCR interaction unveils distinct NF-kappaB pathways in T-cell development and leukemia. EMBO J. 2006;25(5):1000\u20138.","journal-title":"EMBO J"},{"issue":"1","key":"1535_CR25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cell.2007.03.008","volume":"129","author":"QJ Li","year":"2007","unstructured":"Li QJ, Chau J, Ebert PJ, Sylvester G, Min H, Liu G, et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell. 2007;129(1):147\u201361.","journal-title":"Cell"},{"issue":"5","key":"1535_CR26","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1101\/gad.1522907","volume":"21","author":"JR Neilson","year":"2007","unstructured":"Neilson JR, Zheng GX, Burge CB, Sharp PA. Dynamic regulation of miRNA expression in ordered stages of cellular development. Genes Dev. 2007;21(5):578\u201389.","journal-title":"Genes Dev"},{"issue":"5824","key":"1535_CR27","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1126\/science.1141229","volume":"316","author":"TH Thai","year":"2007","unstructured":"Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, et al. Regulation of the germinal center response by microRNA-155. Science. 2007;316(5824):604\u20138.","journal-title":"Science"},{"issue":"5824","key":"1535_CR28","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1126\/science.1139253","volume":"316","author":"A Rodriguez","year":"2007","unstructured":"Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR, et al. Requirement of bic\/microRNA-155 for normal immune function. Science. 2007;316(5824):608\u201311.","journal-title":"Science"},{"key":"1535_CR29","unstructured":"Mature T- and NK-cell neoplasms. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. p.269\u2013319."},{"issue":"7","key":"1535_CR30","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/sj.leu.2405083","volume":"22","author":"CH Lawrie","year":"2008","unstructured":"Lawrie CH, Saunders NJ, Soneji S, Palazzo S, Dunlop HM, Cooper CD, et al. MicroRNA expression in lymphocyte development and malignancy. Leukemia. 2008;22(7):1440\u20136.","journal-title":"Leukemia"},{"issue":"5","key":"1535_CR31","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1182\/blood-2007-06-096784","volume":"111","author":"A Navarro","year":"2008","unstructured":"Navarro A, Gaya A, Martinez A, Urbano-Ispizua A, Pons A, Balagu\u00e9 O, et al. MicroRNA expression profiling in classic Hodgkin lymphoma. Blood. 2008;111(5):2825\u201332.","journal-title":"Blood"},{"key":"1535_CR32","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1182\/blood-2008-10-184077","volume":"113","author":"R Malumbres","year":"2009","unstructured":"Malumbres R, Sarosiek KA, Cubedo E, Ruiz JW, Jiang X, Gascoyne RD, et al. Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. Blood. 2009;113:3754\u201364.","journal-title":"Blood"},{"issue":"5","key":"1535_CR33","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1093\/nar\/gks1439","volume":"41","author":"HI Suzuki","year":"2013","unstructured":"Suzuki HI, Mihira H, Watabe T, Sugimoto K, Miyazono K. Widespread inference of weighted microRNA-mediated gene regulation in cancer transcriptome analysis. Nucleic Acids Res. 2013;41(5):e62.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"1535_CR34","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1038\/leu.2013.121","volume":"27","author":"HI Suzuki","year":"2013","unstructured":"Suzuki HI, Matsuyama H, Noguchi M, Yao T, Komatsu N, Mano H, et al. Computational dissection of distinct microRNA activity signatures associated with peripheral T cell lymphoma subtypes. Leukemia. 2013;27(10):2107\u201311.","journal-title":"Leukemia"},{"issue":"2","key":"1535_CR35","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1182\/blood.V60.2.463.463","volume":"60","author":"BF Haynes","year":"1982","unstructured":"Haynes BF, Hensley LL, Jegasothy BV. Phenotypic characterization of skin-infiltrating T cells in cutaneous T-cell lymphoma: comparison with benign cutaneous T-cell infiltrates. Blood. 1982;60(2):463\u201373.","journal-title":"Blood"},{"issue":"7","key":"1535_CR36","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1182\/blood-2009-12-256719","volume":"116","author":"E Ballabio","year":"2010","unstructured":"Ballabio E, Mitchell T, van Kester MS, Taylor S, Dunlop HM, Chi J, et al. MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential. Blood. 2010;116(7):1105\u201313.","journal-title":"Blood"},{"issue":"3","key":"1535_CR37","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.molonc.2011.02.003","volume":"5","author":"MS Kester van","year":"2011","unstructured":"van Kester MS, Ballabio E, Benner MF, Chen XH, Saunders NJ, van der Fits L, et al. miRNA expression profiling of mycosis fungoides. Mol Oncol. 2011;5(3):273\u201380.","journal-title":"Mol Oncol"},{"key":"1535_CR38","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1038\/cddis.2011.32","volume":"2","author":"MG Narducci","year":"2011","unstructured":"Narducci MG, Arcelli D, Picchio MC, Lazzeri C, Pagani E, Sampogna F, et al. MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in S\u00e9zary syndrome. Cell Death Dis. 2011;2:e151.","journal-title":"Cell Death Dis"},{"issue":"22","key":"1535_CR39","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1182\/blood-2011-06-358382","volume":"118","author":"U Ralfkiaer","year":"2011","unstructured":"Ralfkiaer U, Hagedorn PH, Bangsgaard N, L\u00f8vendorf MB, Ahler CB, Svensson L, et al. Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL). Blood. 2011;118(22):5891\u2013900.","journal-title":"Blood"},{"issue":"2","key":"1535_CR40","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2133.2011.10669.x","volume":"166","author":"J Maj","year":"2012","unstructured":"Maj J, Jankowska-Konsur A, Sadakierska-Chudy A, Noga L, Reich A. Altered microRNA expression in mycosis fungoides. Br J Dermatol. 2012;166(2):331\u20136.","journal-title":"Br J Dermatol"},{"issue":"12","key":"1535_CR41","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.4161\/cc.24987","volume":"12","author":"KL Kopp","year":"2013","unstructured":"Kopp KL, Ralfkiaer U, Gjerdrum LM, Helvad R, Pedersen IH, Litman T, et al. STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma. Cell Cycle. 2013;12(12):1939\u201347.","journal-title":"Cell Cycle"},{"issue":"3","key":"1535_CR42","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/jid.2010.349","volume":"131","author":"L Fits van der","year":"2011","unstructured":"van der Fits L, van Kester MS, Qin Y, Out-Luiting JJ, Smit F, Zoutman WH, et al. MicroRNA-21 expression in CD4\u00a0+\u00a0T cells is regulated by STAT3 and is pathologically involved in S\u00e9zary syndrome. J Invest Dermatol. 2011;131(3):762\u20138.","journal-title":"J Invest Dermatol"},{"issue":"5","key":"1535_CR43","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1038\/jid.2011.481","volume":"132","author":"Y Qin","year":"2012","unstructured":"Qin Y, Buermans HP, van Kester MS, van der Fits L, Out-Luiting JJ, Osanto S, et al. Deep-sequencing analysis reveals that the miR-199a2\/214 cluster within DNM3os represents the vast majority of aberrantly expressed microRNAs in S\u00e9zary syndrome. J Invest Dermatol. 2012;132(5):1520\u20132.","journal-title":"J Invest Dermatol"},{"issue":"8","key":"1535_CR44","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/leu.2011.81","volume":"25","author":"A Watanabe","year":"2011","unstructured":"Watanabe A, Tagawa H, Yamashita J, Teshima K, Nara M, Iwamoto K, et al. The role of microRNA-150 as a tumor suppressor in malignant lymphoma. Leukemia. 2011;25(8):1324\u201334.","journal-title":"Leukemia"},{"key":"1535_CR45","doi-asserted-by":"crossref","unstructured":"Ito M, Teshima K, Ikeda S, Watanabe A, Nara M, Kitadate A, et al. MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6 in advanced cutaneous T-cell lymphoma. Blood. 2014. [Epub ahead of print].","DOI":"10.1182\/blood-2013-09-527739"},{"issue":"24","key":"1535_CR46","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1158\/1078-0432.CCR-11-1192","volume":"17","author":"T Miyagaki","year":"2011","unstructured":"Miyagaki T, Sugaya M, Suga H, Kamata M, Ohmatsu H, Fujita H, et al. IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma. Clin Cancer Res. 2011;17(24):7529\u201338.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"1535_CR47","first-page":"3625","volume":"9","author":"T Ishida","year":"2003","unstructured":"Ishida T, Utsunomiya A, Iida S, Inagaki H, Takatsuka Y, et al. Clinical significance of CCR4 expression in adult T-cell leukemia\/lymphoma: its close association with skin involvement and unfavorable outcome. Clin Cancer Res. 2003;9(10):3625\u201334.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"1535_CR48","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1600-0625.2012.01548.x","volume":"21","author":"MF Benner","year":"2012","unstructured":"Benner MF, Ballabio E, van Kester MS, Saunders NJ, Vermeer MH, Willemze R, et al. Primary cutaneous anaplastic large cell lymphoma shows a distinct miRNA expression profile and reveals differences from tumor-stage mycosis fungoides. Exp Dermatol. 2012;21(8):632\u20134.","journal-title":"Exp Dermatol"},{"issue":"12","key":"1535_CR49","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1182\/blood.V96.12.3681","volume":"96","author":"H Stein","year":"2000","unstructured":"Stein H, Foss HD, D\u00fcrkop H, Marafioti T, Delsol G, Pulford K, et al. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood. 2000;96(12):3681\u201395.","journal-title":"Blood"},{"issue":"5151","key":"1535_CR50","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.8122112","volume":"263","author":"SW Morris","year":"1994","unstructured":"Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin\u2019s lymphoma. Science. 1994;263(5151):1281\u20134.","journal-title":"Science"},{"issue":"7","key":"1535_CR51","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1182\/blood-2007-04-060715","volume":"110","author":"HM Amin","year":"2007","unstructured":"Amin HM, Lai R. Pathobiology of ALK+ anaplastic large-cell lymphoma. Blood. 2007;110(7):2259\u201367.","journal-title":"Blood"},{"issue":"9","key":"1535_CR52","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1200\/JCO.2008.20.9759","volume":"28","author":"R Piva","year":"2010","unstructured":"Piva R, Agnelli L, Pellegrino E, Todoerti K, Grosso V, Tamagno I. Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms. J Clin Oncol. 2010;28(9):1583\u201390.","journal-title":"J Clin Oncol"},{"issue":"18","key":"1535_CR53","doi-asserted-by":"crossref","first-page":"5609","DOI":"10.1158\/1078-0432.CCR-08-2762","volume":"15","author":"YP Moss\u00e9","year":"2009","unstructured":"Moss\u00e9 YP, Wood A, Maris JM. Inhibition of ALK signaling for cancer therapy. Clin Cancer Res. 2009;15(18):5609\u201314.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1535_CR54","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1158\/2159-8290.CD-12-0009","volume":"2","author":"H Mano","year":"2012","unstructured":"Mano H. ALKoma: a cancer subtype with a shared target. Cancer Discov. 2012;2(6):495\u2013502.","journal-title":"Cancer Discov"},{"issue":"37","key":"1535_CR55","doi-asserted-by":"crossref","first-page":"16228","DOI":"10.1073\/pnas.1009719107","volume":"107","author":"O Merkel","year":"2010","unstructured":"Merkel O, Hamacher F, Laimer D, Sifft E, Trajanoski Z, Scheideler M, et al. Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK\u2212 anaplastic large-cell lymphoma. Proc Natl Acad Sci USA. 2010;107(37):16228\u201333.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"1535_CR56","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1182\/blood-2012-08-447375","volume":"122","author":"C Liu","year":"2013","unstructured":"Liu C, Iqbal J, Teruya-Feldstein J, Shen Y, Dabrowska MJ, Dybkaer K, et al. MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma. Blood. 2013;122(12):2083\u201392.","journal-title":"Blood"},{"issue":"18","key":"1535_CR57","doi-asserted-by":"crossref","first-page":"9065","DOI":"10.1128\/JVI.00961-08","volume":"82","author":"FZ Wang","year":"2008","unstructured":"Wang FZ, Weber F, Croce C, Liu CG, Liao X, Pellett PE. Human cytomegalovirus infection alters the expression of cellular microRNA species that affect its replication. J Virol. 2008;82(18):9065\u201374.","journal-title":"J Virol"},{"issue":"3","key":"1535_CR58","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1158\/0008-5472.CAN-08-2886","volume":"69","author":"H Su","year":"2009","unstructured":"Su H, Yang JR, Xu T, Huang J, Xu L, Yuan Y, et al. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res. 2009;69(3):1135\u201342.","journal-title":"Cancer Res"},{"issue":"5908","key":"1535_CR59","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1126\/science.1165395","volume":"322","author":"S Varambally","year":"2008","unstructured":"Varambally S, Cao Q, Mani RS, Shankar S, Wang X, Ateeq B, et al. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science. 2008;322(5908):1695\u20139.","journal-title":"Science"},{"issue":"9","key":"1535_CR60","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1158\/0008-5472.CAN-03-3773","volume":"64","author":"A Ota","year":"2004","unstructured":"Ota A, Tagawa H, Karnan S, Tsuzuki S, Karpas A, Kira S, et al. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res. 2004;64(9):3087\u201395.","journal-title":"Cancer Res"},{"issue":"7043","key":"1535_CR61","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nature03552","volume":"435","author":"L He","year":"2005","unstructured":"He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, et al. A microRNA polycistron as a potential human oncogene. Nature. 2005;435(7043):828\u201333.","journal-title":"Nature"},{"issue":"11","key":"1535_CR62","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1038\/sj.leu.2403942","volume":"19","author":"H Tagawa","year":"2005","unstructured":"Tagawa H, Seto M. A microRNA cluster as a target of genomic amplification in malignant lymphoma. Leukemia. 2005;19(11):2013\u20136.","journal-title":"Leukemia"},{"issue":"1","key":"1535_CR63","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3324\/haematol.2013.088286","volume":"99","author":"E Spaccarotella","year":"2014","unstructured":"Spaccarotella E, Pellegrino E, Ferracin M, Ferreri C, Cuccuru G, Liu C, et al. STAT3-mediated activation of microRNA cluster 17\u00a0~\u00a092 promotes proliferation and survival of ALK positive anaplastic large cell lymphoma. Haematologica. 2014;99(1):116\u201324.","journal-title":"Haematologica"},{"issue":"1","key":"1535_CR64","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.semcancer.2011.12.010","volume":"22","author":"G Kohanbash","year":"2012","unstructured":"Kohanbash G, Okada H. MicroRNAs and STAT interplay. Semin Cancer Biol. 2012;22(1):70\u20135.","journal-title":"Semin Cancer Biol"},{"issue":"26","key":"1535_CR65","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1182\/blood-2011-05-354654","volume":"118","author":"H Matsuyama","year":"2011","unstructured":"Matsuyama H, Suzuki HI, Nishimori H, Noguchi M, Yao T, Komatsu N, et al. miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma. Blood. 2011;118(26):6881\u201392.","journal-title":"Blood"},{"issue":"29","key":"1535_CR66","doi-asserted-by":"crossref","first-page":"11977","DOI":"10.1073\/pnas.1100319108","volume":"108","author":"Q Zhang","year":"2011","unstructured":"Zhang Q, Wang HY, Liu X, Bhutani G, Kantekure K, Wasik M. IL-2R common gamma-chain is epigenetically silenced by nucleophosphin-anaplastic lymphoma kinase (NPM-ALK) and acts as a tumor suppressor by targeting NPM-ALK. Proc Natl Acad Sci USA. 2011;108(29):11977\u201382.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"1535_CR67","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1182\/blood-2011-01-332916","volume":"118","author":"Q Zhang","year":"2011","unstructured":"Zhang Q, Wang H, Kantekure K, Paterson JC, Liu X, Schaffer A, et al. Oncogenic tyrosine kinase NPM-ALK induces expression of the growth-promoting receptor ICOS. Blood. 2011;118(11):3062\u201371.","journal-title":"Blood"},{"issue":"1","key":"1535_CR68","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/path.4171","volume":"230","author":"H Zhu","year":"2013","unstructured":"Zhu H, Vishwamitra D, Curry CV, Manshouri R, Diao L, Khan A, et al. NPM-ALK up-regulates iNOS expression through a STAT3\/microRNA-26a-dependent mechanism. J Pathol. 2013;230(1):82\u201394.","journal-title":"J Pathol"},{"issue":"24","key":"1535_CR69","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1182\/blood-2010-09-301994","volume":"117","author":"C Desjobert","year":"2011","unstructured":"Desjobert C, Renalier MH, Bergalet J, Dejean E, Joseph N, Kruczynski A, et al. MiR-29a down-regulation in ALK-positive anaplastic large cell lymphomas contributes to apoptosis blockade through MCL-1 overexpression. Blood. 2011;117(24):6627\u201337.","journal-title":"Blood"},{"issue":"12","key":"1535_CR70","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1038\/leu.2011.168","volume":"25","author":"E Dejean","year":"2011","unstructured":"Dejean E, Renalier MH, Foisseau M, Agirre X, Joseph N, de Paiva GR, et al. Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas. Leukemia. 2011;25(12):1882\u201390.","journal-title":"Leukemia"},{"issue":"3","key":"1535_CR71","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1182\/blood-2010-08-303305","volume":"117","author":"AL Feldman","year":"2011","unstructured":"Feldman AL, Dogan A, Smith DI, Law ME, Ansell SM, Johnson SH, et al. Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing. Blood. 2011;117(3):915\u20139.","journal-title":"Blood"},{"issue":"7","key":"1535_CR72","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1074\/jbc.M107653200","volume":"277","author":"A Alonso","year":"2002","unstructured":"Alonso A, Merlo JJ, Na S, Kholod N, Jaroszewski L, Kharitonenkov A, et al. Inhibition of T cell antigen receptor signaling by VHR-related MKPX (VHX), a new dual specificity phosphatase related to VH1 related (VHR). J Biol Chem. 2002;277(7):5524\u20138.","journal-title":"J Biol Chem"},{"issue":"3","key":"1535_CR73","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejcb.2012.11.004","volume":"92","author":"Y Wang","year":"2013","unstructured":"Wang Y, Zhang X, Li H, Yu J, Ren X. The role of miRNA-29 family in cancer. Eur J Cell Biol. 2013;92(3):123\u20138.","journal-title":"Eur J Cell Biol"},{"key":"1535_CR74","first-page":"43","volume-title":"Advances in Adult T-Cell Leukemia and HTLV-I Research","author":"M Shimoyama","year":"1992","unstructured":"Shimoyama M. Treatment of patients with adult T-cell leukemia-lymphoma: An overview. In: Takatsuki K, Hinuma Y, Yoshida M, editors. Advances in Adult T-Cell Leukemia and HTLV-I Research. Tokyo: Japan Scientific Societies; 1992. p. 43\u201356."},{"issue":"11","key":"1535_CR75","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1182\/blood-2005-09-3801","volume":"107","author":"A Oshiro","year":"2006","unstructured":"Oshiro A, Tagawa H, Ohshima K, Karube K, Uike N, Tashiro Y, et al. Identification of subtype-specific genomic alterations in aggressive adult T-cell leukemia\/lymphoma. Blood. 2006;107(11):4500\u20137.","journal-title":"Blood"},{"issue":"20","key":"1535_CR76","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1182\/blood-2008-11-189845","volume":"113","author":"M Bellon","year":"2009","unstructured":"Bellon M, Lepelletier Y, Hermine O, Nicot C. Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia. Blood. 2009;113(20):4914\u20137.","journal-title":"Blood"},{"issue":"5","key":"1535_CR77","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3324\/haematol.2010.028605","volume":"96","author":"D Sasaki","year":"2011","unstructured":"Sasaki D, Imaizumi Y, Hasegawa H, Osaka A, Tsukasaki K, Choi YL, et al. Overexpression of Enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia\/lymphoma as a target for epigenetic therapy. Haematologica. 2011;96(5):712\u20139.","journal-title":"Haematologica"},{"issue":"1","key":"1535_CR78","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ccr.2011.12.015","volume":"21","author":"M Yamagishi","year":"2012","unstructured":"Yamagishi M, Nakano K, Miyake A, Yamochi T, Kagami Y, Tsutsumi A, et al. Polycomb-mediated loss of miR-31 activates NIK-dependent NF-\u03baB pathway in adult T cell leukemia and other cancers. Cancer Cell. 2012;21(1):121\u201335.","journal-title":"Cancer Cell"},{"issue":"7427","key":"1535_CR79","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature11606","volume":"492","author":"MT McCabe","year":"2012","unstructured":"McCabe MT, Ott HM, Ganji G, Korenchuk S, Thompson C, Van Aller GS, et al. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature. 2012;492(7427):108\u201312.","journal-title":"Nature"},{"issue":"15","key":"1535_CR80","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1182\/blood-2009-06-222794","volume":"114","author":"Y Yamanaka","year":"2009","unstructured":"Yamanaka Y, Tagawa H, Takahashi N, Watanabe A, Guo YM, Iwamoto K, et al. Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma\/leukemia. Blood. 2009;114(15):3265\u201375.","journal-title":"Blood"},{"issue":"19","key":"1535_CR81","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1182\/blood-2012-06-438135","volume":"120","author":"W Valleron","year":"2012","unstructured":"Valleron W, Ysebaert L, Berquet L, Fataccioli V, Quelen C, Martin A, et al. Small nucleolar RNA expression profiling identifies potential prognostic markers in peripheral T-cell lymphoma. Blood. 2012;120(19):3997\u20134005.","journal-title":"Blood"},{"key":"1535_CR82","doi-asserted-by":"crossref","unstructured":"ZX Yan, LL Wu, K Xue, QL Zhang, Y Guo, M Romer, et al. MicroRNA187 overexpression is related to tumor progression and determines sensitivity to bortezomib in peripheral T-cell lymphoma. Leukemia.2013;9. [Epub ahead of print].","DOI":"10.1038\/leu.2013.291"},{"key":"1535_CR83","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s12185-012-1189-4","volume":"96","author":"M Yamaguchi","year":"2012","unstructured":"Yamaguchi M. Current and future management of NK\/T-cell lymphoma based on clinical trials. Int J Hematol. 2012;96:562\u201371.","journal-title":"Int J Hematol"},{"key":"1535_CR84","doi-asserted-by":"crossref","unstructured":"He Y, Jiang X, Chen J. The role of miR-150 in normal and malignant hematopoiesis. Oncogene. 2013. [Epub ahead of print].","DOI":"10.1038\/onc.2013.346"},{"issue":"7043","key":"1535_CR85","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nature03677","volume":"435","author":"KA O\u2019Donnell","year":"2005","unstructured":"O\u2019Donnell KA, Wentzel EA, Zelller KI, Dang CV, Mendell JT. C-Myc-regulated microRNas modulate E2F1 expression. Nature. 2005;435(7043):839\u201343.","journal-title":"Nature"},{"key":"1535_CR86","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ng.2007.30","volume":"40","author":"TC Chang","year":"2008","unstructured":"Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet. 2008;40:43\u201350.","journal-title":"Nat Genet"},{"issue":"9","key":"1535_CR87","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/j.1349-7006.2007.00531.x","volume":"98","author":"H Tagawa","year":"2007","unstructured":"Tagawa H, Karube K, Tsuzuki S, Ohshima K, Seto M. Synergistic action of microRNA-17 polycistron and MYC in aggressive cancer development. Cancer Sci. 2007;98(9):1482\u201390.","journal-title":"Cancer Sci"},{"issue":"1","key":"1535_CR88","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1182\/blood.V93.1.260","volume":"93","author":"JZ Qin","year":"1999","unstructured":"Qin JZ, Dummer R, Burg G, D\u00f6bbeling U. Constitutive and interleukin-7\/interleukin-15 stimulated DNA binding of Myc, Jun, and novel Myc-like proteins in cutaneous T-cell lymphoma cells. Blood. 1999;93(1):260\u20137.","journal-title":"Blood"},{"key":"1535_CR89","doi-asserted-by":"crossref","unstructured":"Vermeer MH, van Doorn R, Dijkman R, Mao X, Whittaker S, van Voorst Vader PC, et al. Novel and highly recurrent chromosomal alterations in S\u00e9zary syndrome. Cancer Res. 2008 15;68(8):2689\u201398.","DOI":"10.1158\/0008-5472.CAN-07-6398"},{"issue":"8","key":"1535_CR90","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0344-0338(11)80423-1","volume":"190","author":"P Kanavaros","year":"1994","unstructured":"Kanavaros P, Ioannidou D, Tzardi M, Datseris G, Katsantonis J, Delidis G, et al. Mycosis fungoides: expression of C-myc p62 p53, bcl-2 and PCNA proteins and absence of association with Epstein-Barr virus. Pathol Res Pract. 1994;190(8):767\u201374.","journal-title":"Pathol Res Pract"},{"issue":"4","key":"1535_CR91","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ccr.2012.09.003","volume":"22","author":"X Zhang","year":"2012","unstructured":"Zhang X, Zhao X, Fiskus W, Lin J, Lwin T, Rao R, et al. Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas. Cancer Cell. 2012;22(4):506\u201323.","journal-title":"Cancer Cell"},{"issue":"3","key":"1535_CR92","doi-asserted-by":"crossref","first-page":"e59390","DOI":"10.1371\/journal.pone.0059390","volume":"8","author":"V Manf\u00e8","year":"2013","unstructured":"Manf\u00e8 V, Biskup E, Willumsgaard A, Skov AG, Palmieri D, Gasparini P, et al. cMyc\/miR-125b-5p signalling determines sensitivity to bortezomib in preclinical model of cutaneous T-cell lymphomas. PLoS One. 2013;8(3):e59390.","journal-title":"PLoS One"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-014-1535-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-014-1535-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-014-1535-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T18:06:14Z","timestamp":1689012374000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-014-1535-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,25]]},"references-count":92,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["1535"],"URL":"https:\/\/doi.org\/10.1007\/s12185-014-1535-9","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,25]]}}}